Suke Deng

601 total citations · 1 hit paper
11 papers, 409 citations indexed

About

Suke Deng is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Suke Deng has authored 11 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Suke Deng's work include Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Suke Deng is often cited by papers focused on Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Suke Deng collaborates with scholars based in China and United States. Suke Deng's co-authors include Kunyu Yang, Jingshu Meng, Honglin Jin, Jonathan F. Lovell, Yan Hu, Chao Wan, Jing Huang, Gang Wu, Xiaomeng Dai and Lisen Lu and has published in prestigious journals such as Advanced Science, Cancer Letters and Theranostics.

In The Last Decade

Suke Deng

11 papers receiving 407 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma

2023 71 citations Jingshu Meng, Xiao Yang et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suke Deng China	7	216	147	124	90	77	11	409
Mengxue Xu China	5	239 1.1×	125 0.9×	106 0.9×	55 0.6×	101 1.3×	12	404
Jinti Lin China	8	142 0.7×	170 1.2×	97 0.8×	72 0.8×	53 0.7×	10	375
Jiakang Jin China	8	140 0.6×	170 1.2×	97 0.8×	72 0.8×	51 0.7×	10	375
Se Jin Oh South Korea	15	359 1.7×	162 1.1×	190 1.5×	78 0.9×	70 0.9×	22	601
Feyza Gül Özbay Kurt Germany	10	159 0.7×	287 2.0×	192 1.5×	69 0.8×	59 0.8×	14	543
Pedram Torabian Canada	5	156 0.7×	76 0.5×	58 0.5×	79 0.9×	79 1.0×	8	322
Huo Tan China	13	216 1.0×	122 0.8×	115 0.9×	43 0.5×	131 1.7×	43	472

Countries citing papers authored by Suke Deng

Since Specialization

Citations

This map shows the geographic impact of Suke Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suke Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suke Deng more than expected).

Fields of papers citing papers by Suke Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suke Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suke Deng. The network helps show where Suke Deng may publish in the future.

Co-authorship network of co-authors of Suke Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Suke Deng. A scholar is included among the top collaborators of Suke Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suke Deng. Suke Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Zhou, Zhiyuan, Bin Zhang, Yue Deng, et al.. (2024). FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 34–34. 14 indexed citations

2.

Deng, Suke, Jiacheng Wang, Yajie Sun, et al.. (2024). Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells. Journal of Nanobiotechnology. 22(1). 156–156. 3 indexed citations

3.

Deng, Suke, Jiacheng Wang, Yajie Sun, et al.. (2024). Irradiated tumour cell-derived microparticles upregulate MHC-I expression in cancer cells via DNA double-strand break repair pathway. Cancer Letters. 592. 216898–216898. 8 indexed citations

4.

Deng, Yue, Qingyan Chen, Xiao Yang, et al.. (2024). Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment. Theranostics. 14(3). 1224–1240. 23 indexed citations

5.

Wang, Yi‐Jun, Yuxin Yang, Xixi Liu, et al.. (2024). Targeting the Cascade Amplification of Macrophage Colony-stimulating Factor to Alleviate the Immunosuppressive Effects Following Radiotherapy. Research. 7. 450–450. 2 indexed citations

6.

Hu, Yan, Chao Wan, Yang Xiao, et al.. (2023). Radiated tumor cell-derived microparticles effectively kill stem-like tumor cells by increasing reactive oxygen species. Frontiers in Bioengineering and Biotechnology. 11. 1156951–1156951. 2 indexed citations

7.

Sun, Yajie, Yu Tian, Ai Huang, et al.. (2023). Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity. Cell Reports Medicine. 4(12). 101303–101303. 9 indexed citations

8.

Meng, Jingshu, Xiao Yang, Jing Huang, et al.. (2023). Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma. Advanced Science. 10(20). e2300517–e2300517. 71 indexed citations breakdown →

9.

Tian, Yu, Lingyi Kong, Yan Li, et al.. (2023). Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltration. OncoImmunology. 12(1). 2268257–2268257. 6 indexed citations

10.

Dai, Xiaomeng, Jingshu Meng, Suke Deng, et al.. (2020). Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel. Theranostics. 10(7). 3049–3063. 76 indexed citations

11.

Dai, Xiaomeng, Lisen Lu, Suke Deng, et al.. (2020). USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer. Theranostics. 10(20). 9332–9347. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengxue Xu Breakdown of academic impact, for papers by Jinti Lin Breakdown of academic impact, for papers by Jiakang Jin Breakdown of academic impact, for papers by Se Jin Oh Breakdown of academic impact, for papers by Feyza Gül Özbay Kurt Breakdown of academic impact, for papers by Pedram Torabian Breakdown of academic impact, for papers by Huo Tan